Results 241 to 250 of about 640,319 (303)
Some of the next articles are maybe not open access.
Current Opinion in Gastroenterology, 2000
This year's review has been divided into five sections: The first describes the natural history of drug-induced liver disease, the second discusses the issue of placebo-related increases in liver-associated enzymes, the third describes agents newly reported to cause hepatic injury, the fourth discusses new reports of hepatic injury from established ...
W, Mayoral, J H, Lewis
openaire +4 more sources
This year's review has been divided into five sections: The first describes the natural history of drug-induced liver disease, the second discusses the issue of placebo-related increases in liver-associated enzymes, the third describes agents newly reported to cause hepatic injury, the fourth discusses new reports of hepatic injury from established ...
W, Mayoral, J H, Lewis
openaire +4 more sources
Current Opinion in Internal Medicine, 2003
The year 2002 saw a warning from the US Food and Drug Administration not to use the diet agent, Lipokinetix, and brought to light a few new agents as potential hepatotoxins. Numerous other reports confirmed the hepatotoxicity of several previously described agents.
David, Novak, James H, Lewis
openaire +3 more sources
The year 2002 saw a warning from the US Food and Drug Administration not to use the diet agent, Lipokinetix, and brought to light a few new agents as potential hepatotoxins. Numerous other reports confirmed the hepatotoxicity of several previously described agents.
David, Novak, James H, Lewis
openaire +3 more sources